Clinical Center of Excellence

Young African American student studying a microscope in a laboratory.jpg
Onward Logo.png

Our Commitment To Breast Cancer Patients

At Context Therapeutics, we are passionate about improving health and committed to helping people with cancer.

Through our Onward Breast Cancer Clinical Trials, we will evaluate Apristor (Onapristone extended release) as a monotherapy (ONWARD 201) and in combination (ONWARD 202) with standard of care drugs across multiple metastatic breast cancer treatment lines. 



Our Clinical Center of Excellence (CCE) will enable Context to build a robust and scalable clinical development organization that is capable of meeting the expectations of patients and clinicians to ensure efficient clinical trial enrollment, execution, and communication.